Ligand validation:6I98

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 6I98 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6I98_C8E_A_906	21%	68%	0.213	0.901	0.62	0.63	-	-	0	0	57%	1
6I98_C8E_A_909	18%	63%	0.272	0.864	0.65	0.77	-	-	0	0	100%	1
6I98_C8E_A_907	18%	75%	0.247	0.913	0.57	0.4	-	-	0	0	57%	1
6I98_C8E_A_908	13%	81%	0.235	0.871	0.47	0.35	-	-	0	0	48%	1
8RM3_C8E_A_913	27%	86%	0.185	0.833	0.39	0.34	-	-	2	0	100%	1
2VQI_C8E_B_1638	100%	84%	0.037	0.989	0.38	0.39	-	-	0	0	100%	1
8XWO_C8E_A_402	94%	77%	0.046	0.989	0.45	0.46	-	-	2	0	76%	1
2GR7_C8E_D_1342	83%	75%	0.098	0.955	0.42	0.56	-	-	2	0	100%	1
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	4	0	100%	1
3QRC_C8E_B_1	76%	86%	0.113	0.95	0.37	0.36	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.